Primary Human Cardiomyocytes and Cardiofibroblasts Treated with Sera from Myocarditis Patients Exhibit an Increased

Kamil A Kobak1, Paweł Franczuk1,2, Justyna Schubert3

  • 1Laboratory for Applied Research on Cardiovascular System, Department of Heart Diseases, Wroclaw Medical University, 50-556 Wroclaw, Poland.

Cells
|April 30, 2021
PubMed

Insights

Myocarditis (MCD) alters iron homeostasis in heart cells. Increased iron demand in cardiomyocytes and cardiofibroblasts correlates with patient inflammation and neurohormonal activation, suggesting iron dysregulation in MCD.

Area of Science:

  • Cardiovascular Biology
  • Cellular Metabolism
  • Immunology

Background:

  • Myocarditis (MCD) involves cardiac fibroblasts and cardiomyocytes.
  • Iron homeostasis is crucial for cellular function.
  • The role of iron status in MCD pathophysiology is unclear.

Purpose of the Study:

  • To investigate the impact of systemic inflammation in acute MCD on cardiac cells.
  • To explore alterations in iron homeostasis pathways in cardiomyocytes and cardiofibroblasts exposed to MCD sera.

Main Methods:

  • Primary human cardiomyocytes (hCM) and cardiofibroblasts (hCF) were cultured with sera from MCD patients and controls.
  • RNA sequencing was performed to analyze gene expression changes.
  • Expression of iron metabolism genes, including transferrin receptor 1 (TFR1) and ferritin, was evaluated.

Main Results:

  • MCD sera induced significant gene expression alterations in hCM and hCF.
  • Increased expression of TFR1 and ferritin was observed in MCD serum-treated cells, indicating heightened iron demand.
  • TFR1 expression correlated with elevated patient inflammation markers (IL-6, CRP) and neurohormonal activation (NT-proBNP).

Conclusions:

  • Cardiac cell dysfunction in MCD may be linked to disrupted iron homeostasis.
  • Increased cellular iron demand is a feature of MCD and associated with clinical severity.
  • These findings highlight iron metabolism as a potential therapeutic target in myocarditis.